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Abstract. The interaction of homologous and heterol- 
ogous albumin-gold complex (Alb-Au) with capillary 
endothelium was investigated in the mouse lung, 
heart, and diaphragm. Perfusion of the tracer in situ 
for from 3 to 35 min was followed by washing with 
phosphate-buffered saline, fixation by perfusion, and 
processing for electron microscopy. From the earliest 
time examined, one and sometimes two rows of 
densely packed particles bound to some restricted 
plasma membrane microdomains that appeared as 
uncoated pits, and to plasmalemmal vesicles open on 
the luminal front. Morphometric analysis, using var- 
ious albumin-gold concentrations, showed that the 
binding is saturable at a very low concentration of the 
ligand and short exposure. After 5 min, tracer-carry- 
ing vesicles appeared on the abluminal front, discharg- 
ing their content into the subendothelial space.  As a 
function of tracer concentration 1-10% of plasmalem- 
mal vesicles contained Alb-Au particles in fluid phase; 
from 5 min on, multivesicular bodies were labeled by 
the tracer. Plasma membrane, coated pits, and coated 
vesicles were not significantly marked at any time in- 
terval. Heparin or high ionic strength did not displace 
the bound Alb-Au from vesicle membrane. No bind- 
ing was obtained when Alb-Au was competed in situ 
with albumin or was injected in vivo. Gold complexes 
with fibrinogen, fibronectin, glucose oxidase, or poly- 
ethyleneglycol did not give a labeling comparable to 
that of albumin. These results suggest that on the cap- 
illary endothelia examined, the Alb-Au is adsorbed on 
specific binding sites restricted to uncoated pits and 
plasmalemmal vesicles. The tracer is transported in 
transcytotic vesicles across endothelium by receptor- 
mediated transcytosis, and to a lesser extent is taken 
up by pinocytotic vesicles. The existence of albumin 
receptors on these continuous capillary endothelia 
may provide a specific mechanism for the transport of 
albumin and other molecules carried by this protein. 
BUMIN is largely responsible for the oncotic pressure of 
plasma and interstitial fluid and serves as a carrier for 
important molecules such as fatty acids, testosterone, 
estradiol, and thyroid hormones (4, 7,  12,  16, 36). In heart 
myocytes (12) and hepatocytes (16), it has been shown that 
the uptake of fatty acids is mediated by an albumin receptor. 
Although the endothelial transport of serum albumin was 
extensively investigated, the cellular mechanism of this phe- 
nomenon is unknown. Physiological  data obtained have been 
interpreted by some investigators to be indicative of a preva- 
lent convective process (15, 21, 31), whereas others consider 
that the estimation  of albumin  transport  by the  so-called 
"albumin  escape rate"  lacks any physiological significance 
(17, 18). Estimates of lymph/plasma  ratio revealed that the 
amount of albumin passing from plasma into the interstitial 
fluid varies greatly from one organ to another (6,  19, 20, 23, 
33, 38-40). Considering the type ofendothelium (continuous, 
fenestrated, discontinuous) encountered in these various or- 
gans,  no  firm  correlation  can  be  established between the 
endothelial structure and the rate of  albumin transport. Thus, 
other properties of endothelial cell may account for the re- 
markable difference  in the rate, speed, and kinetics of  albumin 
uptake in various tissues. 
We report evidence that in the capillary endothelium of  the 
mouse lung, heart,  and diaphragm, the  albumin  transport 
occurs by a process  that implies specific  adsorption on binding 
sites restrictively located to plasmalemmal vesicles. Part of 
these results were previously presented in abstract form (l l, 
26). 
Materials and Methods 
Animals 
Adult male RAP mice, 25-30 g, were kept for a week in standard housing and 
feeding conditions,  and  16  h before experiments  they were deprived of food 
(water was given ad lib.). 
Reagents 
Crystallized bovine serum albumin (BSA) was purchased from Mann Research 
Laboratories,  New York; mouse albumin,  fraction  V, and heparin,  grade I, 
from Sigma Chemical Co., St,  Louis, MO; glucose oxidase (12  U/rag) from 
Merck,  Darmstadt,  Federal  Republic  of Germany);  tetrachloroauric  acid 
(HAuCh) and bovine fibrinogen from BDH Chemicals Ltd., Poole, England; 
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NY; and native ferritin 6x crystallized,  cadmium free,  pl 3.9-4.2, from Miles 
Laboratories, Inc., Elkhart,  IN. Human plasma fibronectin was prepared ac- 
cording to the method of Vuento and Vahcri (35). 
Preparation of Colloidal Gold 
Colloidal gold particles with an average diameter of 5 nm were prepared by 
reducing HAuCL.  with white phosphorus (28).  To the monodisperse solution 
of colloidal  gold,  one  of the  following  macromolecules  was  added  in  the 
concentration (per milliliter Au solution) indicated:  BSA, pl 4.75  (100 tzg), (b) 
mouse albumin, pl 4.7 (100 t~g); as other plasma proteins we used (c) bovine 
fibrinogen, pl 4.3--4.55  (100 ug) and (d) human fibronectin, pI 6.0 (30 ug); as 
a nonplasmatic protein we used (e) glucose oxidase, pl  3.8-5.2 (100 ug); and 
as an uncharged molecule we used (f) PEG, 3,/, 20,000 ( 1 mg). The pl values 
were determined by chromatofocusing in a fast protein liquid chromatography 
system using a Mono P column equilibrated with 20 mM bis Tris-HCI buffer, 
pH  6.4,  and  eluted  with  Polybuffcr  74  pH  4.0  (Pharmacia  Biotechnology, 
Uppsala,  Sweden). All  mixtures were centrifuged at  170,000  g  for  1 h;  the 
pellets  were resuspended in  phosphate-buffered saline (PBS).  The complexes 
obtained were mouse albumin-gold, bovine albumin-gold, collectively  termed 
Alb-Au, fibrinogen-gold, fibronectin-gold, glucose oxidase-gold, and PEG-Au. 
The pl of one complex, as estimated by isoelectrofocusing in  1% Agarose IEF, 
Pharmalyte pH 3.5-10.0  (Pharmacia Biotechnology), was not much different 
from that of the protein used, e.g.,  Alb-Au, pl  5.2  (vs.  albumin pl 4.75).  As 
determined by ~251-BSA adsorbtion, 1 ml gold colloid at a concentration having 
o~c,,  As,~,m =  0.1 was found to retain 18-40 ug BSA (different tracer preparations). 
Before use, the solutions were centrifuged for 5  min at  ~12,000  g; aliquots 
examined by electron microscopy showed that the complexes were in mono- 
meric dispersion. 
Experiments with Albumin-Gold 
In Situ. The inquiry was addressed to three capillary networks provided with 
continuous endothelium: lung, heart, and diaphragm. For heart and diaphragm 
experiments, after ether anesthesia and laparotomy, a catheter introduced into 
the abdominal aorta was used as inlet, and another catheter was placed into 
vena cava abdominalis as outlet. The vasculature was washed free of blood by 
perfusing PBS at 37"C for 5 rain at a flow rate of 3 ml/min. For experiments 
on lung, after thoracotomy, a catheter was placed into the pulmonary artery, 
and the right atrium was cut open.  In most experiments we used BSA-gold 
complex as  probe. Alb-Au at  37"C  and  at  concentrations corresponding to 
Asls.m =  0.1 and 0.4 was perfused continuously at a flow rate of 3 ml/min for 
3,  5,  or  10 rain.  In lung experiments the tracer at concentration  of 0.4 was 
administered intermittently in 0.l-ml aliquots for 3, 5,  10,  15, and 35 rain, to 
a  total  of 1.0 ml. The unbound tracer was washed out by perfusing PBS,  at 
37*(?, 3 mi/min, for 3 min.  Fixation was carried out by perfusing either the 
triple fixative  (27) or 2.5%  formaldehyde,  1.5% glutaraldehyde, and 2.5  mM 
CaCI2 in 0.1  M HCI-Na cacodylate buffer, pH 7.4; immersing tissue specimens 
for 60 min in the triple fixative;  then staining en bloc with 0.5% uranyl acetate. 
Specimens  were  embedded  in  EPOn-812  by  the  standard  procedure.  Thin 
sections cut on an American Optical Ultracut Microtome (American Optical 
Scientific  Instruments, Buffalo,  NY) or a  Reichert Ultramicrotome (Reichert 
Scientific  Instruments, Buffalo,  NY) were stained with uranyl acetate and lead 
citrate, and examined with a Philips 400-HM electron microscope. 
In Vivo. After anesthesia and laparotomy, the portal vein and hepatic artery 
were  ligated  to  minimize the  tracer  uptake  by the  liver.  200  ul  Alb-Au  at 
concentration  of A~.~°'~ =  8.0 was injected  into the iliac  vein.  After 3  rain, 
small fragments of heart and diaphragm were fixed by immersion in the same 
aldehyde  mixture  as  above,  then  postfixed  in  buffered  OsO4  and  further 
processed for electron microscopy. 
Control Experiments 
Control experiments were of the same general design as the Alb-Au experiments 
in situ, but with certain distinctive steps. 
Competition with Albumin. The lung vasculature was washed free of blood 
with PBS containing 0, 0.1, 0.25,  1.0, 2.5, and 30 mg/ml BSA. The tracer (Alb- 
0  lem  Au at A5i5,~ =  0.1),  perfused for 3 min, and the post-tracer PBS contained the 
same  concentration  of competing  albumin.  In  diaphragm  and  heart,  this 
competition was done with 3% BSA only. 
Effect of  High Ionic Strength. After perfusion of I ml Alb-Au (A°i~s~ = 0.1 ) 
and 20 mg native ferritin pl 3.9-4.2 in PBS, the vessels were washed with  10 
Abbreviations used in this paper." Alb-Au, albumin-gold complex; PEG, poly- 
ethyleneglycol. 
mI PBS containing 0.45 M NaCL 
Competition  with  Heparin.  To  elucidate  if charge  interactions  play  any 
significant role in the binding of the Alb-Au to the endothelial cell surface, we 
paralleled  the high ionic strength effect with competition experiments using as 
a  competitor a  strongly anionic macromolecule, heparin.  Perfusion was per- 
formed for 3 min with the above mentioned mixture of tracers and then with 
PBS, both containing 4 mg/ml of heparin. 
Experiments with Fibrinogen-Gold.  The tracer perfused was 6 ml fibrinogen- 
gold given over 3 rain. 
Experiments with Fibronectin-Gold.  Instead of Alb-Au, 6 ml of fibronectin- 
gold were perfused for 3 rain. 
Experiments with Glucose Oxidase-Gold.  The vasculature was perfused with 
6 ml of the gold complex with this nonplasmaric protein, at the same flow rate 
as above. 
Experiments with PEG-Gold.  Performed both  in  situ and  in  vivo,  these 
procedures consisted of perfusing, instead of Alb-Au, similar amounts of PEG- 
Au for from 3 to 10 min (in situ) or 3 min (in vivo). 
Specimens collected  from all these control experiments were prepared for 
electron microscope examination as described above. 
Morphometric Analysis. To assess the saturability of Alb-Au binding, 6 ml 
tracer at concentrations of A°i~,~m =  0.01, 0.025, 0.05, 0,1, 0.25, 0.53, and 0.95 
were continuously perfused through the lung at 2 ml/min under the general 
experimental conditions described above under In Situ. The effect of competing 
BSA on Alb-Au binding was quantitated by including in this morphometric 
analysis the set of experiments described under Competition with Albumin. 
For each experiment six blocks were selected  from different regions of the lung 
and 30 micrographs were taken randomly at the same magnification. On each 
print at a  fnal magnification of 97,500  the integrated  lengths of the plasma 
membrane proper profile and of the uncoated pits and plasmalemmal vesicles 
open to the capillary lumen were measured with a  planimeter (Keuffel and 
Esser Co.,  Switzerland).  Concomitantly,  the gold  particles within the three 
topographical locations were recorded. 
Results 
General 
The interaction of Alb-Au with endothelium was similar in 
the  three  capillary  beds  examined  but  the  transendothelial 
passage of  this complex was more rapid and more pronounced 
in the lung than in the heart and diaphragm microvessels. As 
a general pattern, the Alb-Au binding was restricted to some 
microdomains of the plasma membrane appearing as small 
(~ 100-150 nm in diameter) uncoated pits, and to the mem- 
brane of plasmalemmal vesicles. In these two locations most 
particles were characteristically adsorbed in one or sometimes 
two  rows.  Although the  endothelial  transit  is  known to be 
slow  and  relatively  reduced  in  situ,  Alb-Au  was  markedly 
transported by vesicles through the endothelial cell, and to a 
lesser extent was also internalized into multivesicular bodies. 
The results obtained with homologous (mouse) and heterol- 
ogous (bovine) albumin were similar. 
Binding of  Alb-Au 
From  the  earliest  time  points  examined  (3  min),  Alb-Au 
particles were  characteristically bound  primarily  to two  re- 
stricted  microdomains  of the  luminal  endothelial  surface: 
small uncoated pits (Fig.  1), and the great majority (-90%) 
of open plasmalemmal vesicles (Figs. 2 and 3).  Transitional 
forms between labeled uncoated pits and labeled vesicles were 
frequently detected. Vesicle diaphragms were not particularly 
conspicuous, though a fuzz could be observed in some cases 
(Fig. 3).  The plasma membrane and coated pits were essen- 
tially unlabeled. As seen in cross-section, particles were usu- 
ally adsorbed on vesicle membrane in a single or two rows at 
an average density of-  10-15 particles per vesicle profile cut 
at its largest diameter (-80 nm) (Figs.  2 and 3). In -10% of 
plasmalemmal vesicles, Alb-Au particles appeared randomly 
Ghitescu et al. Specific Binding Sites  for Albumin  1305 Figures 1-3. These and all other figures illustrate the interaction of bovine serum Alb-Au with alveolar capillary endothelium at different time 
intervals of tracer perfusion in the mouse lung. Abbreviations used in Figs. 1-10: ec, endothelial cell; e, endosome; v, plasmalemmal vesicle;/, 
lumen; p, pericyte; pro, plasma membrane. Fig.  h  At 3 min, one or two rows of Alb-Au particles were adsorbed on uncoated pits (arrows) of 
the luminal aspect of the endothelial cell (ec). Extremely rare particles could be detected on plasma membrne (arrowhead).  Fig. 2: At 3 min, 
most plasmalemmal vesicles open on the luminal front (v~) or apparently internalized (v2) were marked by one or two rows of densely packed 
particles adsorbed on  vesicle  membrane. In v3, the  section is probably tangential through a  labeled vesicle.  Polymorphic, larger  vesicles 
contained an amorphous osmophilic material (in contrast to the relatively clear content of plasmalemmal vesicles [washed by PBS]), tentatively 
identified as endosomes (e) were marked by various number of particles.  Fig. 3: At 5 min, while separate (v) or fused plasmalemmal vesicles 
(vj) were  marked by adsorbed Alb-Au particles,  most of these were  accumulated within tubulovacuolar structures tentatively identified as 
endosomes (e). The structure in el probably belongs to another endothelial cell (tangential section through junction, j). v2, tangentially cut 
vesicles. Bar,  1 #m for all figures. 
distributed, suggesting a fluid-phase uptake (Fig. 6). The mor- 
phometric analysis of the Alb-Au binding at different tracer 
concentrations showed that the plasmalemmal vesicle mem- 
brane had an affinity for Alb-Au five to six times higher than 
the  plasma  membrane  proper  (Fig.  I 1).  The  shape  of the 
curve depicting the  number of Alb-Au particles bound per 
micrometer real length of open plasmalemmal vesicle mem- 
brane as a  function of tracer concentration suggested, within 
a  rather large dispersion of values, that the degree of vesicle 
labeling increased with ligand concentration before reaching 
a  saturation level of ~60 gold granules/vm of vesicle surface 
profile. 
Transcytosis of Alb-A u 
At 3  to  5  min, some labeled vesicles were apparently inter- 
nalized while maintaining the one or two  rows of adsorbed 
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concentration, a number of vesicles were detected discharging 
their content  on  the  abluminal endothelial front:  particles 
appeared shortly retarded against the basal lamina (Figs. 4- 
7).  At  10  min,  Alb-Au particles were seen  in the  subendo- 
thelial interstitia (Fig. 7).  Occasionally, tracer particles were 
detected along transendothelial channels  and  beyond their 
abluminal openings (Fig. 5).  Alb-Au particles were not ob- 
served in  intercellular junctions  at  any  time  interval.  The 
appearance of Alb-Au particles in  the  subendothelium  was 
usually more rapid in the lung than in heart and diaphragm 
capillaries. 
Figures 4-7. Fig. 4: At 10 min, transcytotic vesicles (v) opened on the abluminal front of endothelium (ec).  Bar, 0.1  um. Fig. 5: At 5 min, 
occasional transendothelial channels (c) were marked by Alb-Au particles, some of which occurred at their abluminal opening (arrow).  V, a 
transcytotic vesicle discharging its particles into the subendothelial interstitium, b/, basal lamina; ep, alveolar epithelial cell type I1. Bar, 0.1 um. 
Fig. 6: Characteristic picture at 10 min and longer intervals: Alb-Au panicles were adsorbed on the membrane of most plasmalemmal vesicles 
in different locations (v) including those open on the abluminal front (v~), mark vesicles in which the uptake appeared to be in fluid phase (vt), 
and decorated multivesicular bodies (my). Bar, 0.2 #m. Fig. 7: At 35 min (arrow) numerous Alb-Au particles appeared in the pericapillary 
space (ps), apparently discharged by vesicles open on the abluminal front (vt). Some panicles occurred in the luminal part of the intercellular 
space (is) but were absent from the abluminal part of the latter (as) beyond the junction (j). Bar, 0.1 um. 
Ghitescu  et al. Specific Binding Sites  for Albumin  1307 Figures 8-10. Fig. 8: While plasmalemmal vesicles were consistently  labeled by Alb-Au particles,  neither coated pits (cp) nor coated vesicles 
(cv) bound  significantly  this  tracer.  Bar,  0.1  um.  Fig. 9:  Competition  with  3%  albumin  inhibited  the  characteristic  Alb-Au  labeling  of 
plasmalemmal vesicles which only rarely contained few particles, whereas a number of multivesicular  bodies (my)  were marked by the tracer 
(inset). Bars,  1 um for Fig. 9 and inset.  Fig. 10: Alveolar capillary,  3 min after perfusion  with glucose oxidase-Au complex:  particles labeled 
almost uniformly the plasma membrane, some vesicle diaphragms (v), and plasmalemmal vesicles (V~). At this time interval,  multivesicular 
bodies (my) were not marked by the tracer. Small aggregates (a) were seldom encountered,  b/, basal lamina. Bar, 0.2 urn. 
Fluid-Phase Endocytosis of  ,4  lb-A u 
Although coated pits and coated vesicles were barely marked 
by  Alb-Au  (Fig.  8),  ~10%  of total  plasmalemmal  vesicles 
contained such particles taken up in fluid phase (Fig. 6). At 5 
min, many multivesicular bodies were labeled by the particles 
located within  their matrix (Fig.  6). Concomitantly,  various 
quantities  of tracer  were  observed  in  polymorphic  tubulo- 
vacuolar  features  (~150-250  nm  in  diameter),  which  dis- 
played a  slightly osmiophilic material. These structures were 
tentatively  identified  as  components  of the  endosomal  or 
prelysosomal  compartment  (Figs.  2  and  3).  At  later  time 
points ( 15 to 35 min) tracer particles could be seen in vacuoles, 
presumably  lysosomes, containing  autophagic  material.  Al- 
though  endosomes and  lysosomes cannot be identified with 
certainty  solely  on  morphologic grounds,  the  accumulation 
of Alb-Au  in  easily distinguishable  multivesicular  bodies  is 
evidence that the tracer is delivered to the lysosome compart- 
ment.  In  the  lung,  the  extent  of labeling  of the  latter  was 
slightly increased from ~20-30%  at  10 rain,  to ~60%  at 35 
min  after Alb-Au perfusion.  Higher concentration  of tracer 
apparently did not result in a parallel increase in the number 
of marked multivesicular bodies. 
Controls 
In  Vivo Experiments.  Labeling of plasmalemmal vesicles by 
Alb-Au particles was markedly reduced as compared with in 
situ  experiments,  both  in  terms  of percentage  of  marked 
vesicles (< 10%) and in number of particles per vesicle (about 
two) that usually occupied the center of vesicle. Plasmalemma 
and coated pits were not decorated, but some multivesicular 
bodies were  labeled by  few particles.  The  overall  aspect  of 
Alb-Au interaction with endothelium was quite similar to that 
observed after competition with albumin. 
Competition with Albumin. Competition with albumin gave 
results  largely  similar  to  those  emerged  from  the  in  vivo 
experiments  (see  above):  while  transcytosis  of Alb-Au  was 
practically  abolished,  a  certain  degree  of endocytosis  still 
occurred, as demonstrated by the decoration  of some multi- 
vesicular bodies (Fig.  9). Fig.  12 shows the effect of different 
concentrations  of competing BSA on Alb-Au binding to the 
membrane of uncoated pits and luminally open plasmalem- 
mal vesicles, as estimated by morphometry. Colloid particles 
with  o l  cm  Asjsnm =  0.1, had  18-40 #g BSA adsorbed per milliliter 
gold sol and were 50%  less bound to the vesicle membrane 
when competed with ~ 100 ~g/ml albumin. 
High Ionic Strength.  High  ionic  strength  resulted  in  the 
displacement  of native  ferritin  but  not  of Alb-Au  particles 
from the interior of plasmalemmal vesicles. 
Competition  with Heparin.  Competition with heparin did 
not impair the binding of Alb-Au but prevented the adsorp- 
tion of native ferritin. 
Experiments  with Fibrinogen-gold, Fibronectin-gold,  and 
PEG-gold.  In  our  experimental  conditions,  none  of these 
tracers  was  significantly  bound  to  plasmalemma  proper  or 
coated pits. Very rare vesicles or their diaphragms contained 
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Figure 11.  The number of Alb-Au panicles bound per micrometer 
length of membrane, as a function of tracer concentration. Dotted 
line: particle density on the plasma membrane proper. Continuous 
line: density of the tracer on the plasmalemmal vesicle membrane 
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For each experimental condition a 50-80-~m length ofendothelium 
was analyzed. 
q,/ 
t- 
.~0- 
E 
~OJ 
wE 
o) 
[-  c/) 
•  .~  ,,.6  zo. 
13, 
r- 
E 
1  2  3 
competing BSA (mg/mt) 
Figure 12. Alb-Au binding to the plasmalemmal vesicle membrane 
as a  function of concentration of competing albumin. 60-80 #m of 
vesicle membrane profile length was analyzed for each experiment. 
one or two particles. Occasionally, multivesicular bodies were 
marked by few particles. Glucose oxidase-gold complex, ex- 
posing a  nonplasmatic protein ofpI 3.8-5.2 comparable to 
albumin (pI 4.75), decorated rather uniformly plasma mem- 
brane, coated pits, and plasmalemmal vesicles (Fig.  10). 
Discussion 
These studies reveal: (a) the  specific adsorptive binding of 
Alb-Au complex to plasmalemmal vesicles, and (b) provide 
evidence for the transport of  Alb-Au complex across capillary 
endothelium of mouse lung,  heart, and  diaphragm.  In  the 
endothelia investigated in these experiments, both homolo- 
gous and heterologous albumin gave similar binding patterns: 
the data presented refer to heterologous albumin. 
Alb-Au binds specifically and saturably to uncoated pits of 
plasma membrane and to most (~90%) plasmalemmal vesi- 
cles. The binding is not electrostatic in nature since high ionic 
strength or competition with a negatively charged macromol- 
ecule such as heparin does not displace the adsorbtive binding 
of Alb-Au (pI 5.1) but prevents the vesicle uptake of the even 
more anionic native ferritin (pI 3.8-4.2). The binding of Alb- 
Au is, however, abolished by the endogenous albumin (exper- 
iments in vivo) and by exogenous albumin (in situ). Morpho- 
metric analysis of the competition experiments with albumin 
indicates that Alb-Au and monomeric albumin compete with 
similar affinities for a  limited number of the same binding 
sites located on the plasmalemmal vesicle membrane. Colloi- 
dal gold complexes with other plasma proteins such as fibrin- 
ogen and  fibronectin as well  as PEG-Au do not bind in  a 
significant manner to vesicles. The uniform, undiscriminating 
binding of glucose oxidase-gold (pI 3.8-5.2) appears to be a 
nonspecific electrostatic interaction comparable to that  re- 
ported for other nonphysiologic membrane markers of similar 
pI such as hemeundecapeptide (4.3) and anionic hemeunde- 
capeptide (3.85) (reference 9). The scarcity of Alb-Au binding 
to plasma membrane does not support the postulate that in 
vivo, albumin  is electrostatically attached to a  fiber matrix 
covering the endothelium (5). The number of densely packed 
Alb-Au  particles  adsorbed  to  vesicle  membrane  is  much 
greater than expected from a Poisson distribution (for com- 
parison with the ferritin labeling of similar vesicle, see refer- 
ence 2). This indicates that the vesicle loading with Alb-Au 
does not depend solely on the diffusion from the lumen but 
on strong attractive forces on the vesicle membrane. All of 
these results suggest that Alb-Au complex binding to endo- 
thelial uncoated pits and plasmalemmal vesicles is mediated 
by specific  binding sites  or receptors. Recently, Sage et al. 
have reported that a unique albumin-binding glycoprotein is 
constitutively synthesized by bovine,  porcine,  and  human 
endothelial cells in culture. Immunofluorescence staining of 
endothelial ceils showed a granular distribution for this 43K 
protein (22). 
Endothelial transport of Alb-Au complex takes place both 
by vectorial transcytosis (vesicles), and by convective transcy- 
tosis  (channels)  (24-26).  Such  observations  together  with 
those reporting vesicular transport of other plasma constitu- 
ents such as low density lipoproteins (32,  34),  glycosylated 
albumin (38,  39), albumin and fibrinogen (40),  and insulin 
(14,  30) strongly contradict the hypothesis on the nonfunc- 
tionality of endothelial vesicles in transport coined by Bund- 
gaard et al. (3) and Frokjaer-Jensen (8). Since binding of Alb- 
Au complex is not affected by high ionic strength and strongly 
anionic heparin  but is  abolished by competition with  low 
concentrations of free albumin, it appears that in lung, heart, 
and diaphragm capillaries  the endothelial passage of Alb-Au 
takes place at least in part by receptor-mediated transcytosis. 
There is  a  suggestion  that  some  of the  Alb-Au-carrying 
vesicles  are  formed upon binding of ligand  to its  receptor 
followed by their clustering in uncoated pits.  This presump- 
tion  has  to  be  checked  by  experiments with  monovalent 
tracer. A similar ligand binding to uncoated pits was formerly 
observed during interaction of low density lipoprotein with 
arterial endothelium in situ (34). 
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vesicles, and multivesicular bodies are labeled by this tracer, 
the carriers to this compartment are probably a  fraction of 
plasmalemmal vesicles that contain the ligand in fluid phase. 
This is supported by the observation that Alb-Au endocytosis 
is not abolished by albumin competition; it is presumed that 
this process is nonspecific, as seems to be the case with the 
pinocytosis of the control tracers used in  our experiments. 
Accordingly, it can be assumed that plasmalemmal vesicles, 
although uniform in structure, actually represent at least two 
populations of functionally different vesicles: transcytotic ves- 
icles (the vast majority) and pinocytic vesicles (a small frac- 
tion). Though most endothelial vesicles appear to be consti- 
tutive (24), at least some may be formed by substrate-induced 
vesiculation, as suggested by transitional forms (from pit to 
vesicle) detected in these experiments. The routing to multi- 
vesicular bodies may either express a normal alternative path- 
way for albumin or be the consequence of the fact that Alb- 
Au is a multivalent ligand. 
Taking into account the broad differences in the lymph/ 
plasma concentration of albumin in various organs (33),  as 
well as endothelial structural and functional characteristics in 
each capillary network, modulation in the density and affinity 
of endothelial  albumin  binding  sites  may  occur  from  one 
vascular bed to another. 
The absence of Alb-Au labeling of coated pits in the en- 
dothelia examined is at variance with the strong and exclusive 
Alb-Au  binding  to coated pits in  the endothelium  of liver 
sinusoids (10). In vivo, specific binding sites for albumin may 
secure the uptake of the minimum amount of this protein or 
its associated molecules needed by a given tissue. Upon recep- 
tor  saturation,  more  albumin  can  be  transported  in  fluid 
phase. 
The case of albumin transport is not unique; as reported, 
other plasma molecules cross the endothelium by adsorptive 
or receptor-mediated transcytosis: low density lipoprotein (32, 
34),  transferrin (13,  29), glycosylated albumin (38,  39), and 
insulin (14, 30). 
Albumin binding sites constitute a  relatively large family 
present on hepatitis B  viruses (1), prokaryotes (streptococcus 
[37]),  and  eukaryotes  (hepatocytes  [16],  heart  myocytes 
[121). 
It is known that in addition to its role in maintaining the 
colloid osmotic pressure of plasma and interstitial fluid,  al- 
bumin is also an important carrier for various molecules (fatty 
acids,  testosterone, estradiol,  thyroid hormones), which are 
presented by the ligand at the surface of the target cell (4,  12, 
16). Accordingly, the receptor-mediated transcytosis of albu- 
min in endothelium represents not only a transport mecha- 
nism for albumin per se but also the albumin-mediated deliv- 
ery of other important molecules required by the metabolic 
needs of various tissues. 
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